As pro-apoptotic mechanisms of JNK activation have been described in a pancreatic cancer cell line [36], preserved antineoplastic efficiency should be confirmed for different cancer types and treatments separately. The gene discussed is MAPK8; the disease is familial pancreatic carcinoma.